This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Miyarisan Pharmaceutical Co., Ltd.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Miki Kamikawa: Innovator in Peptide Research
Introduction
Miki Kamikawa is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of peptide research, particularly in the development of solutions to combat health issues caused by certain bacteria.
Latest Patents
Kamikawa holds a patent for a peptide that inhibits the production of toxins by bacteria belonging to the genus Clostridium. This innovation aims to provide a means for preventing, treating, and controlling health damages, including food poisoning and infections. The cyclic peptide he developed contains the sequence Cys-Phe-Trp-Ala-His, which plays a crucial role in its effectiveness.
Career Highlights
Throughout his career, Miki Kamikawa has been associated with Miyarisan Pharmaceutical Co., Ltd., where he has focused on advancing peptide-based solutions. His work has garnered attention for its potential impact on public health.
Collaborations
Kamikawa has collaborated with notable colleagues, including Tohru Shimizu and Kaori Ohtani, who have contributed to his research endeavors.
Conclusion
Miki Kamikawa's innovative work in peptide research highlights the importance of scientific advancements in addressing health challenges. His contributions continue to pave the way for future developments in the field.